Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
AIChE Annual MeetingAIChE Annual Meeting
Not Confirmed
Not Confirmed
02-06 November, 2025
Not Confirmed
Not Confirmed
03-06 November, 2025
Not Confirmed
Not Confirmed
03-05 November, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
AIChE Annual MeetingAIChE Annual Meeting
Industry Trade Show
Not Confirmed
02-06 November, 2025
Industry Trade Show
Not Confirmed
03-06 November, 2025
Industry Trade Show
Not Confirmed
03-05 November, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

20 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251020795690/en/Enanta-Pharmaceuticals-Presents-New-Data-for-Zelicapavir-its-N-Protein-Inhibitor-and-EDP-323-its-L-Protein-Inhibitor-Both-in-Development-for-the-Treatment-of-Respiratory-Syncytial-Virus-RSV-at-IDWeek-2025

07 Oct 2025
// PHARMIWEB
https://www.pharmiweb.com/press-release/2025-10-07/enanta-pharmaceuticals-to-present-data-for-zelicapavir-and-edp-323-two-candidates-in-development-fo

02 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251002172271/en/Enanta-Pharmaceuticals-Announces-Closing-of-Upsized-Public-Offering-of-Common-Stock-Including-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares

30 Sep 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/enantas-rsv-treatment-misses-main-goal-mid-stage-study-2025-09-29/

30 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250930643683/en/Enanta-Pharmaceuticals-Announces-Pricing-of-Upsized-Public-Offering-of-Common-Stock

30 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250930487224/en/Enanta-Pharmaceuticals-Announces-Proposed-Public-Offering-of-Common-Stock
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE